Related Experiment Video
Updated: Jun 16, 2026
08:05
An Efficient Method for Directed Hepatocyte-Like Cell Induction from Human Embryonic Stem Cells
Published on: May 6, 2021
Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells
Yuyou Duan1, Xiaocui Ma, Xiaochui Ma
1Transplant Research Program, University of California Davis Medical Center, Sacramento, California, USA.
Stem Cells (Dayton, Ohio)
|February 6, 2010
Summary
Human embryonic stem cells were differentiated into functional hepatocytes. These human embryonic stem cell-derived hepatocytes exhibit complete metabolic function comparable to primary liver cells, advancing cell-based therapeutics and drug development.
Area of Science:
- Stem cell biology
- Hepatocyte differentiation
- Drug metabolism research
Background:
- Human embryonic stem cells (hESCs) offer potential for generating functional hepatocytes.
- Clinical applications and drug development require reliable sources of hepatocytes.
Purpose of the Study:
- To efficiently differentiate hESCs into mature, functional hepatocytes.
- To assess the metabolic capabilities of hESC-derived hepatocytes (hEH) compared to primary human hepatocytes (hPH).
Main Methods:
- Enrichment of hESCs to definitive endoderm (DE).
- Differentiation of DE into hepatic progenitors and subsequently hepatocytes.
- Assessment of cell markers (CXCR4, SOX17, FOXA2, alpha-feto protein, albumin).
- Analysis of drug metabolism using ultraperformance liquid chromatography-tandem mass spectrometry.
Main Results:
- Successfully generated a homogenous population of hEH with high purity (>90% albumin positive).
- hEH demonstrated a complete biotransformation system, including phase I, II, and III enzymes and transporters.
- Identified seven metabolic pathways for bufuralol in hEH, including four novel pathways.
- hEH exhibited drug-metabolizing capacity comparable to hPH for four tested drugs.
Conclusions:
- Generated mature, metabolically functional hepatocytes from hESCs.
- hEH possess comparable drug metabolism capabilities to primary human hepatocytes.
- This represents a significant advancement for cell-based therapeutics and pharmacological/toxicological studies.
